Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Ivermectin
Eco Animal Health Limited
QP54AA01
Ivermectin
18.7 milligram(s)/gram
Oral paste
LM: Licensed Merchant as defined in relevant national legislation
Horses
ivermectin
Endectoparasiticides
Authorised
2006-11-10
Health Products Regulatory Authority 13 April 2018 CRN000W1F Page 1 of 6 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Animec 18.7 mg/g Oral Paste for Horses 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Ivermectin 18.7 mg/g EXCIPIENT(S): For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral Paste A white homogeneous paste 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of nematode or arthropod infection due to: Large strongyles: _Strongylus vulgaris_ (adults and L 4 stage larvae [arterial]) _Strongylus edentatus_ (adults and L 4 stage larvae [tissue]) _Strongylus equinus_ (adults) Small strongyles (including benzimidazole resistant strains): _Cyathostomum spp _(adults and luminal L 4 stage larvae) _Cylicocyclus spp_. (adults and luminal L 4 stage larvae) _Cylicodontophorus spp_. (adults and luminal L 4 stage larvae) _Cylicostephanus spp_. (adults and luminal L 4 stage larvae) _Gyalocephalus spp_. (adults and luminal L 4 stage larvae) Ascarids: _Parascaris equorum_ (luminal L 5 larvae and adults) Pinworms: Health Products Regulatory Authority 13 April 2018 CRN000W1F Page 2 of 6 _Oxyuris equi_ (L 4 stage larvae and adults) Neck threadworms: _Onchocerca spp_ (microfilariae) Stomach bots: _Gasterophilus spp_ (oral and gastric stages) 4.3 CONTRAINDICATIONS Do not use in cases of hypersensitivity to the active substance or to any of the excipients. Do not use in dogs or cats as severe adverse reactions may occur. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Some horses with heavy infections of _Onchocerca_ spp. microfilariae have experienced oedema and pruritus following treatment, such reactions are assumed to be the result of death of large numbers of microfilariae. These signs resolve within a few days but symptomatic treatment may be advisable. Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: · Too f Read the complete document